Downloaded from information about the cost bene®t of care 10 . But there are still many gaps in our understanding of how expectations affect quality of life. A better knowledge would help us to improve quality of life assessment and more closely meet expectations in the future.
Expectations and quality of life have long been thought related. In 1984, Calman proposed that quality of life represented the gap between expectation and the reality of the situation 1 . A narrowing of this gap, either by improving experience or by lowering expectations, could enhance quality of life. The model is valuable because it acknowledges the highly individual nature of quality of life and the in¯uence of culture and past experience. But the relationship between quality of life and expectations is complex. Critics can rightly assert that, according to the Calman theory, patients with lower expectations, such as those from deprived communities, have better quality of life than those with higher expectations but the same experience. Other factors, such as whether individuals wish to trade off between time and function, may be important 2 .
In this issue of the JRSM (pp. 621±628) Dr Koller and co-workers report how they sought to relate expectations and quality of life among 55 cancer patients undergoing radiotherapy. Although the number of patients was small and represents referrals to a specialist regional centre rather than a general population of cancer patients, the ®ndings move forward thinking in this ®eld and raise questions for practice and research.
First, 35 of the 55 patients had expectations of`healing', preventing metastases' or`preventing tumour relapse' despite the fact that`curative' (sic) treatment was intended in only 19 of these patients. This result has several possible explanations. There may be an unrealistic expectation among patients for`healing', de®ciencies in communication between professionals and patients, limitations in the questionnaire that the authors developed to assess treatment expectations, or, as Koller et al. propose, optimists may have better coping strategies than pessimists. Evidence elsewhere lends support to all these theories. Slevin et al. 3 found that many patients attending a specialist cancer centre were keen to opt for toxic treatment despite low chances of cure' 4 . Communication and information-giving in cancer settings is often unsatisfactory and a cause for complaint 4 ; treatment response and survival is dif®cult to predict 5 , with some doctors and nurses feeling uneasy about discussing treatments that are not aimed to cure 6 . Questionnaires about sensitive issues such as treatment expectations are dif®cult to develop, require extensive validation and are often incomplete 7 .
Second, there was a positive correlation betweeǹ healing' expectations and quality of life before radiotherapy, healing expectation being the only signi®cant predictor variable in multiple regression analysis. Whether those patients with higher quality of life scores, and probably higher physical function, were more prone to report an expectation of`healing', or those expecting healing' were more positive about their quality of life, cannot be determined from these data. What is most fascinating is that quality of life ratings dropped rapidly among the 15 patients whose`healing' expectation was not ful®lled six weeks after radiotherapy. Was this an effect of disappointment? Such a ®nding has wide-reaching implica-tionsÐthere are many circumstances, in practice and research, when patients expect a positive outcome or to receive a service. Or was there deterioration in this particular group because their cancers were either unresponsive to radiotherapy or progressing more rapidly? Longitudinal and larger studies are needed to answer these questions.
One dif®culty with research on quality of life and expectations is that these are not constant concepts. Perceptions of health, quality of life, wellbeing, and expectations and their meaning vary between individuals and within an individual over time. These perceptions are in¯uenced by the experience of the person and, in turn, are in¯uenced by the culture and beliefs of the person and those around him or her. Many of the existing quality of life measures, including those used in this study, do not take account of this, imposing standardized measures of quality of life which mean that they do not accurately re¯ect the actual circumstances of the individuals considered 8, 9, 10 . Methodologies for assessment of quality of life need a better understanding of the individualized wants and preferences of the persons in different cultures and with different experiences. Too often, assessments of both expectations and quality of life are neglected in research and practice; the work by Koller et al. moves us forward in this regard.
Optimizing quality of life among patients is a common objective of treatment in many conditions. Reports of quality of life are used more and more to monitor the effects of care, to aid needs assessment and to provide
John Swales
John Swales, my predecessor as editor of the JRSM, was browsing in the university bookshop at Leicester when his heart stopped. A wide circle of people will feel themselves diminished by his death on 17 October.
John's main area of research was hypertension, and in the world of science the name of Swales is often coupled with salt. On many a platform, during the`Great Salt Debate', he made the case against sodium chloride restriction, which he judged of negligible value. He was a dynamic and humorous man who could readily ®ll a lecture hall. As an editor in those days I consulted John on questions of hypertension and the kidney, but much more often I wanted his counsel on general matters such as developments in the National Health Service, the state of clinical research, the conduct of the pharmaceutical industry. With his penetrating intelligence he was quietly in¯uential in many areas, subversive in the best sense.
Near retirement from the Leicester Chair, John's journalistic instincts led him to the JRSM, but in late 1995, after a year, he resigned the editorship to take up the post of Director of the NHS Research and Development Programme. Many friends saw this as a rash move and so it proved, because he never quite learned to work the Whitehall system. Emerging three years later, and with the smile now restored to his face, he had leisure to pursue a new phase of creative activity in which clinical medicine joined hands with philosophy and the history of science. A substantial book awaits publication. A lesser fruit of these re¯ections was the JRSM paper Three Cultures in Need of Integration (August 2000), in which he proposed a way to reconcile the old con¯icts between observational science, numerical analysis and clinical practice. Wisdom of this sort, based on polymathic scholarship, is not easily found. John's premature death is a heavy loss not only to family and friends but also to humane medicine.
